Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S − 1 therapy

BACKGROUND: Although docetaxel plus S-1 adjuvant chemotherapy after gastrectomy with D2 lymphadenectomy has been a standard of treatment for stage III gastric cancer, there is no established chemotherapy for patients with recurrence during or within six months after the completion of adjuvant doceta...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Toshifumi, Kawakami, Hisato, Sakai, Daisuke, Kurokawa, Yukinori, Shimokawa, Toshio, Goto, Masahiro, Satoh, Taroh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288074/
https://www.ncbi.nlm.nih.gov/pubmed/35840917
http://dx.doi.org/10.1186/s12885-022-09844-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288074/
https://www.ncbi.nlm.nih.gov/pubmed/35840917
http://dx.doi.org/10.1186/s12885-022-09844-2

Ejemplares similares